Veritas In Silico (TSE:130A) Days Sales Outstanding : 0.00 (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Veritas In Silico Days Sales Outstanding?

Veritas In Silico's average Accounts Receivable for the three months ended in Dec. 2024 was 円51.7 Mil. Veritas In Silico's Revenue for the three months ended in Dec. 2024 was 円0.0 Mil.

The historical rank and industry rank for Veritas In Silico's Days Sales Outstanding or its related term are showing as below:

TSE:130A' s Days Sales Outstanding Range Over the Past 10 Years
Min: 26.63 Med: 44.49 Max: 75.85
Current: 75.85

During the past 4 years, Veritas In Silico's highest Days Sales Outstanding was 75.85. The lowest was 26.63. And the median was 44.49.

TSE:130A's Days Sales Outstanding is ranked worse than
53.97% of 843 companies
in the Biotechnology industry
Industry Median: 69.63 vs TSE:130A: 75.85

Veritas In Silico's Days Sales Outstanding stayed the same from Sep. 2023 (0.00) to Dec. 2024 (0.00).

Veritas In Silico Days Sales Outstanding Historical Data

The historical data trend for Veritas In Silico's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veritas In Silico Days Sales Outstanding Chart

Veritas In Silico Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Days Sales Outstanding

26.63

40.94

48.04

75.09

Veritas In Silico Quarterly Data
	Dec21	Dec22	Sep23	Dec23	Mar24	Jun24	Dec24
Days Sales Outstanding	Get a 7-Day Free Trial			-	66.46	85.81	45.58	-

Competitive Comparison of Veritas In Silico's Days Sales Outstanding

For the Biotechnology subindustry, Veritas In Silico's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Veritas In Silico's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Veritas In Silico's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Veritas In Silico's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

Veritas In Silico Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Veritas In Silico's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

	Days Sales Outstanding (A: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (59.07	+	21.019)	/	2 )	/	194.643	*	365
=	40.0445					/	194.643	*	365
=	75.09

Veritas In Silico's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding (Q: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2024 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (82.315	+	21.019)	/	2 )	/	0	*	365 / 4
=	51.667					/	0	*	365 / 4
=	N/A

Veritas In Silico (TSE:130A) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Veritas In Silico Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Veritas In Silico's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Veritas In Silico Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Veritas In Silico Inc (TSE:130A) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

1-11-1, Nishigotanda, Shinagawa-ku, Tokyo, JPN, 141-0031

Website

https://www.veritasinsilico.com

Veritas In Silico Inc is engaged in discovery of mRNA-targeted small molecule and antisense oligonucleotide drugs. It has ibVIS platform that combines informatics (i) and experimental biology at Veritas In Silico (VIS) that will bring to fruition mRNA-targeted drugs.

Veritas In Silico Headlines

No Headlines